Hana Pharm Co., Ltd.
293480.KS
Get informed when a big investor buys or sells
+ FollowMarket Cap$150.11B
Close$
Share Statistics
| Market cap | $150.11 Billion |
|---|---|
| Enterprise Value | $208.63 Billion |
| Dividend Yield | $260.00 (3.07%) |
| Earnings per Share | $507 |
| Beta | 0.33 |
| Outstanding Shares | 17,723,000 |
Return
| Return on Equity | 5.26% |
|---|---|
| Return on Assets | 3.91% |
| Return on Invested Capital | 7.48% |
Valuation & Multiples
| P/E Ratio | 8.62 |
|---|---|
| PEG | 16.3 |
| Price to Sales | 0.59 |
| Price to Book Ratio | 0.44 |
| Enterprise Value to Revenue | 0.84 |
| Enterprise Value to EBIT | 7.3 |
| Enterprise Value to Net Income | 11 |
| Total Debt to Enterprise | 0.34 |
| Debt to Equity | 0.21 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 14, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
$62.50 B
Average shareholder expectationNext Earnings Call
Expected Date
November 18, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
$67.80 B
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Hana Pharm Co., Ltd.
730 employees
CEO: Taehong Choi Hana Pharm Co., Ltd. is a pharmaceutical enterprise that manufactures and supplies a diverse range of medicinal goods to both domestic South Korean and international markets. Its comprehensive product line covers various therapeutic cate...